The aim of this study is to formulate and characterize streptomycin-loaded apoferritin nanoparticles (ApoStrep NPs) for their potential therapeutic use in bacterial resistant infections (i.e. tuberculosis). ApoStrep NPs were prepared by disassembly/reassembly process via pH method and changing apoferritin/drug molar ratio, purified by dialyses process also associated with gel filtration chromatography and characterized in their chemico-physical and technological parameters as yield, size distribution, polidispersivity, morphology, internal structure, zeta potential and loading efficacy. The results showed that spherical reproducible NPs could be obtained by using apoferritin/drug molar ratio lower than 1:25 and purification based on the combination of dialysis and gel filtration chromatography. Photon correlation spectroscopy, Uv–visible detection and electron microscopy showed the maintenance of the native apoferritin chemico-physical properties and structure. When formulated with apoferritin/drug 1:10 and 1:25 molar ratio, ApoStrep NPs showed remarkable encapsulation efficacy (35% and 28%, respectively) along with kinetic profile of drug delivery, approximately 15% at 37 °C in 72 h, as evidenced by “in vitro” release experiments.

Apoferritin nanocage as streptomycin drug reservoir: Technological optimization of a new drug delivery system / Ruozi, Barbara; Veratti, Patrizia; Vandelli, Maria Angela; Tombesi, Andrea; Tonelli, Massimo; Forni, Flavio; Pederzoli, Francesca; Belletti, Daniela; Tosi, Giovanni. - In: INTERNATIONAL JOURNAL OF PHARMACEUTICS. - ISSN 0378-5173. - 518:1-2(2017), pp. 281-288. [10.1016/j.ijpharm.2016.12.038]

Apoferritin nanocage as streptomycin drug reservoir: Technological optimization of a new drug delivery system

RUOZI, Barbara;VERATTI, PATRIZIA;VANDELLI, Maria Angela;TOMBESI, Andrea;TONELLI, Massimo;FORNI, Flavio;PEDERZOLI, FRANCESCA;BELLETTI, Daniela;TOSI, Giovanni
2017

Abstract

The aim of this study is to formulate and characterize streptomycin-loaded apoferritin nanoparticles (ApoStrep NPs) for their potential therapeutic use in bacterial resistant infections (i.e. tuberculosis). ApoStrep NPs were prepared by disassembly/reassembly process via pH method and changing apoferritin/drug molar ratio, purified by dialyses process also associated with gel filtration chromatography and characterized in their chemico-physical and technological parameters as yield, size distribution, polidispersivity, morphology, internal structure, zeta potential and loading efficacy. The results showed that spherical reproducible NPs could be obtained by using apoferritin/drug molar ratio lower than 1:25 and purification based on the combination of dialysis and gel filtration chromatography. Photon correlation spectroscopy, Uv–visible detection and electron microscopy showed the maintenance of the native apoferritin chemico-physical properties and structure. When formulated with apoferritin/drug 1:10 and 1:25 molar ratio, ApoStrep NPs showed remarkable encapsulation efficacy (35% and 28%, respectively) along with kinetic profile of drug delivery, approximately 15% at 37 °C in 72 h, as evidenced by “in vitro” release experiments.
23-dic-2016
518
1-2
281
288
Apoferritin nanocage as streptomycin drug reservoir: Technological optimization of a new drug delivery system / Ruozi, Barbara; Veratti, Patrizia; Vandelli, Maria Angela; Tombesi, Andrea; Tonelli, Massimo; Forni, Flavio; Pederzoli, Francesca; Belletti, Daniela; Tosi, Giovanni. - In: INTERNATIONAL JOURNAL OF PHARMACEUTICS. - ISSN 0378-5173. - 518:1-2(2017), pp. 281-288. [10.1016/j.ijpharm.2016.12.038]
Ruozi, Barbara; Veratti, Patrizia; Vandelli, Maria Angela; Tombesi, Andrea; Tonelli, Massimo; Forni, Flavio; Pederzoli, Francesca; Belletti, Daniela; Tosi, Giovanni
File in questo prodotto:
File Dimensione Formato  
IJP-D-16-02261Rev1.pdf

embargo fino al 23/12/2017

Tipologia: Post-print dell'autore (bozza post referaggio)
Dimensione 6.04 MB
Formato Adobe PDF
6.04 MB Adobe PDF Visualizza/Apri
IJP-D-16-02261Rev1.pdf

non disponibili

Tipologia: Versione dell'editore (versione pubblicata)
Dimensione 6.04 MB
Formato Adobe PDF
6.04 MB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1131700
Citazioni
  • ???jsp.display-item.citation.pmc??? 4
  • Scopus 17
  • ???jsp.display-item.citation.isi??? 11
social impact